登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《OFID，3月21日，High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with Coronavirus Disease 2019》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-03-23

  • High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with Coronavirus Disease 2019

    Wei Cao, M.D, Xiaosheng Liu, PhD, Tao Bai, M.D, Hongwei Fan, M.D, Ke Hong, M.D, Hui Song, M.D, Yang Han, PhD, Ling Lin, M.D, Lianguo Ruan, M.D, Taisheng Li, M.D, PhD Author Notes

    Open Forum Infectious Diseases, ofaa102, https://doi.org/10.1093/ofid/ofaa102

    Published: 21 March 2020

    Abstract

    The outbreak of Coronavirus Disease 2019 (COVID-19) has spread rapidly in China. Till now, no definite effective treatment has been identified. We reported on three patients of severe COVID-19 who received high-dose intravenous immunoglobulin (IVIg) with satisfactory recovery. Based on these observations, randomized studies of high-dose IVIg should be considered in deteriorating patients infected with COVID-19.

  • 原文来源：https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofaa102/5810740?searchresult=1
10浏览量
原文链接
相关报告

  • 《MedRxiv，3月6日，Immunodepletion with Hypoxemia: A Potential High Risk Subtype of Coronavirus Disease 2019》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-07
    • Immunodepletion with Hypoxemia: A Potential High Risk Subtype of Coronavirus Disease 2019 Lilei Yu, Yongqing Tong, Gaigai Shen, Aisi Fu, Yanqiu Lai, Xiaoya Zhou, Yuan Yuan, Yuhong Wang, Yuchen Pan, Zhiyao Yu, Yan Li, Tiangang Liu, Hong Jiang doi: https://doi.org/10.1101/2020.03.03.20030650 Abstract Background The outbreak of COVID-2019 is becoming a global public health emergency. Although its basic clinical features have been reported, the dynamic characteristics of immune system in COVID-2019 patients, especially those critical patients with refractory hypoxemia, are not yet well understood. We aim to describe the dynamic characteristics of immune system in 3 critical patients with refractory hypoxemia, and discuss the relationship between hypoxemia severity and immune cell levels, and the changes of gut microbes of COVID-2019 patient. Methods This is a retrospective study from 3 patients with 2019-nCoV infection admitted to Renmin Hospital of Wuhan University, a COVID-2019 designated hospital in Wuhan, from January 31 to February 6, 2020. *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.
    12浏览量
    原文链接

  • 《MedRxiv，3月8日，Acute Myocardial Injury of Patients with Coronavirus Disease 2019》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-09
    • Acute Myocardial Injury of Patients with Coronavirus Disease 2019 Huayan Xu, Keke Hou, Hong Xu, Zhenlin Li, Huizhu Chen, Na Zhang, Rong Xu, Hang Fu, Ran Sun, Lingyi Wen, Linjun Xie, Hui Liu, Kun Zhang, Joseph B Selvanayagam, Chuan Fu, Shihua Zhao, Zhigang Yang, Ming Yang, Yingkun Guo doi: https://doi.org/10.1101/2020.03.05.20031591 Abstract Background: Since the outbreak of the Coronavirus Disease 2019 (COVID-19) in China, respiratory manifestations of the disease have been observed. However, as a fatal comorbidity, acute myocardial injury (AMI) in COVID-19 patients has not been previously investigated in detail. We investigated the clinical characteristics of COVID-19 patients with AMI and determined the risk factors for AMI in them. Methods: We analyzed data from 53 consecutive laboratory-confirmed and hospitalized COVID-19 patients (28 men, 25 women; age, 19-81 years). We collected information on epidemiological and demographic characteristics, clinical features, routine laboratory tests (including cardiac injury biomarkers), echocardiography, electrocardiography, imaging findings, management methods, and clinical outcomes. *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.
    158浏览量
    原文链接